ICD-10-GM

ICD-10-GM-Code G13.0*

You are here: Startseite > ICD-10-GM > G00-G99 > G10-G14 > G13*

- ICD-10-GM
Internationale statistische Klassifikation der Krankheiten und verwandter Gesundheitsprobleme (ICD-10)
- G00-G99
Krankheiten des Nervensystems
- G10-G14
Systematrophien, die vorwiegend das Zentralnervensystem betreffen
- G13*
Systematrophien, vorwiegend das Zentralnervensystem betreffend, bei anderenorts klassifizierten Krankheiten

G13.0*

Paraneoplastische Neuromyopathie und Neuropathie

ICD-10-GM Code G13.0* für Paraneoplastische Neuromyopathie und Neuropathie

Karzinomatöse Neuromyopathie (C00-C97†)

Sensorische paraneoplastische Neuropathie, Typ Denny-Brown (C00-D48†)

ICD-10
ATC
ICD-10 International Statistical Classification of Diseases and Related Health Problems 10th Revision
ICD-10

ICD-10 is the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD), a medical classification list by the World Health Organization (WHO).

It contains codes for diseases, signs and symptoms, abnormal findings, complaints, social circumstances, and external causes of injury or diseases.

ATC

The Anatomical Therapeutic Chemical (ATC) Classification System is used for the classification of active ingredients of drugs according to the organ or system on which they act and their therapeutic, pharmacological and chemical properties.

It is controlled by the World Health Organization Collaborating Centre for Drug Statistics Methodology (WHOCC).

DDD

The defined daily dose (DDD) is a statistical measure of drug consumption, defined by the World Health Organization (WHO).

It is used to standardize the comparison of drug usage between different drugs or between different health care environments.

Home Contact Us